Ribolia
Kunshan, CN · 2 known investors
Ribolia (瑞博生物) is a pioneer in RNAi technology and small nucleic acid drug development, with research platforms covering drug delivery, chemical modification, and multi-target drug development. The company serves patients with chronic diseases including cardiovascular, metabolic, kidney, and liver conditions through its siRNA pipeline.
Founders & leadership
梁
梁子才Founding Chairman & Chief Executive Officer
张
张鸿雁Founding President
甘
甘黎明Co-Chief Executive Officer & Global President of R&D
Investors · 2
In the news
Frequently asked questions
- What does Ribolia do?
- Ribolia (瑞博生物) is a pioneer in RNAi technology and small nucleic acid drug development, with research platforms covering drug delivery, chemical modification, and multi-target drug development. The company serves patients with chronic diseases including cardiovascular, metabolic, kidney, and liver conditions through its siRNA pipeline.
- Who founded Ribolia?
- Ribolia was founded by 梁子才, 张鸿雁.
- Who are Ribolia's investors?
- Ribolia's investors include Blue Ocean Capital Group, Pan-Lin Capital.
- Where is Ribolia headquartered?
- Ribolia is headquartered in Kunshan, CN.